Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

LL-37: Cathelicidin Antimicrobial Peptide Structure

LL-37 is the only cathelicidin antimicrobial peptide identified in humans. It is a 37-residue alpha-helical peptide derived from the C-terminal domain of the human cathelicidin precursor protein hCAP18, cleaved by proteinase 3.

Structure and Mechanism

The amphipathic alpha-helical structure of LL-37 allows it to interact with bacterial membranes through electrostatic attraction to negatively charged phospholipid head groups. The hydrophobic face then inserts into the lipid bilayer, disrupting membrane integrity.

Beyond Antimicrobial Activity

Research has revealed that LL-37 functions beyond direct antimicrobial killing. It modulates chemotaxis, promotes angiogenesis, and influences wound healing pathways. Its interaction with formyl peptide receptor-like 1 (FPRL1) mediates many of these immunomodulatory effects.

Research Applications

LL-37 is studied in antimicrobial resistance, wound healing, and innate immunity research. Its broad-spectrum activity against gram-positive and gram-negative bacteria, fungi, and enveloped viruses makes it a valuable research tool.